Loading...
Rising Regulatory Hurdles And US Tariffs Will Undermine Biosimilar Margins
AnalystLowTarget's Fair Value
CHF 38.02
29.3% overvalued intrinsic discount04 Sep
CHF 49.17
1Y
30.7%7D
1.0%1Y
30.7%7D
1.0%You can edit this narrative until Aug 25 10:25 PM. Then, changes will post as Updates.